Like a modern-day Rip Van Winkle, I returned to the claims analytics industry in 2017 after a decade-long hiatus. Unlike Rip Van Winkle, I recently discovered that nothing has changed about the fascination that health system executives have with “state data”.
With the announcement by the Department of Health and Human Services (HHS) of the January 1, 2019 effective date of new, and lower, payments for drugs acquired under the 340B program, I was reminded of a post that my friend Wes Chapman published a little more than a..
Market share is “top of mind” for every savvy health system executive in America, even if definitions of market share are imprecise. Most often, health system executives think about market share in terms of the “PSA” and “SSA”, which is an elegant way of referring..
Status quo, as everyone knows, is Latin for the existing state of affairs, particularly in a political context. Ironically, the reliance on governmental and political organizations as the source of data analytics is the status quo for thousands of U.S. hospitals.
In 2007, I presented this paper to the Chief Strategy & Innovation Officer of the CDC and the EVP of Benefits of Wal-Mart proposing that they develop a Wal-Mart Provider Network and a Wal-Mart Health Plan with Humana. Wal-Mart estimated that the analysis would save..
It’s been a tumultuous year for Facebook. On top of the privacy scandal surrounding inappropriate data usage by Cambridge Analytica, they saw the worst single-day loss for any public company in history after an investor call on July 26. With questions around the..
Today is the first day of HIMSS 2018, a conference being held in Las Vegas in an exposition center in which the cheapest 10’ x 10’ booth costs $3,600 plus a $400 “booth listing fee” and attended by a number of people who speak frequently of the waste that is in..
The end of 2017 brings tidings of anything but great joy for health system executives. Consider what has happened in just the last 45 days:
There is a seemingly never-ending opportunity to innovate in healthcare, particularly companies from California founded by technologists who have recently encountered the monolith that is the US healthcare system. Having experienced it once in an up-close and..